Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
Metformin, the world’s most widely used anti-diabetic drug, can slow ageing, according to a study by Belgian Dr Wouter De Haes.
In experiments reported in the journal Proceedings of the National Academy of Sciences, the research teases out the mechanism behind Metformin’s age-slowing effects. The drug causes an increase in the number of toxic oxygen molecules released in the cells, which increases cell robustness and longevity in the long term.
Mitochondria – the energy factories in cells – generate tiny electric currents to provide the body’s cells with energy. Highly reactive oxygen molecules are produced as a by-product of this process.
While these molecules are harmful because they can damage proteins and DNA and disrupt normal cell functioning, a small dose can actually do the cell good, Dr Wouter De Haes says.
It was long thought that harmful reactive oxygen molecules were the causes of ageing. The food and cosmetics industries are quick to emphasise the ‘anti-ageing’ qualities of products containing antioxidants, such as skin creams, fruit and vegetable juices, red wine and dark chocolate.
But while antioxidants do neutralise harmful reactive oxygen molecules in the cell, they negate metformin’s anti-ageing effects because the drug relies entirely on these molecules to work.
The researchers studied Metformin’s mechanism in the tiny roundworm Caenorhabditis elegans, an ideal species for studying ageing because it has a lifespan of only three weeks.
Other studies in humans have shown that metformin suppresses some cancers and heart disease. Metformin could even be an effective drug for counteracting the general effects of ageing, say the researchers.
The study was carried out by Wouter De Haes under the supervision of Liesbet Temmerman and Professor Liliane Schoofs (KU Leuven) and in close collaboration with Professor Bart Braeckman (Ghent University).